-
Olympic Games in northern Italy have German twist
-
Bad Bunny: the Puerto Rican phenom on top of the music world
-
Snapchat blocks 415,000 underage accounts in Australia
-
At Grammys, 'ICE out' message loud and clear
-
Dalai Lama's 'gratitude' at first Grammy win
-
Bad Bunny makes Grammys history with Album of the Year win
-
Stocks, oil, precious metals plunge on volatile start to the week
-
Steven Spielberg earns coveted EGOT status with Grammy win
-
Knicks boost win streak to six by beating LeBron's Lakers
-
Kendrick Lamar, Bad Bunny, Lady Gaga triumph at Grammys
-
Japan says rare earth found in sediment retrieved on deep-sea mission
-
San Siro prepares for last dance with Winter Olympics' opening ceremony
-
France great Benazzi relishing 'genius' Dupont's Six Nations return
-
Grammy red carpet: black and white, barely there and no ICE
-
Oil tumbles on Iran hopes, precious metals hit by stronger dollar
-
South Korea football bosses in talks to avert Women's Asian Cup boycott
-
Level playing field? Tech at forefront of US immigration fight
-
British singer Olivia Dean wins Best New Artist Grammy
-
Hatred of losing drives relentless Alcaraz to tennis history
-
Kendrick Lamar, Bad Bunny, Lady Gaga win early at Grammys
-
Surging euro presents new headache for ECB
-
Djokovic hints at retirement as time seeps away on history bid
-
US talking deal with 'highest people' in Cuba: Trump
-
UK ex-ambassador quits Labour over new reports of Epstein links
-
Trump says closing Kennedy Center arts complex for two years
-
Reigning world champs Tinch, Hocker among Millrose winners
-
Venezuelan activist ends '1,675 days' of suffering in prison
-
Real Madrid scrape win over Rayo, Athletic claim derby draw
-
PSG beat Strasbourg after Hakimi red to retake top spot in Ligue 1
-
NFL Cardinals hire Rams' assistant LaFleur as head coach
-
Arsenal scoop $2m prize for winning FIFA Women's Champions Cup
-
Atletico agree deal to sign Lookman from Atalanta
-
Real Madrid's Bellingham set for month out with hamstring injury
-
Man City won't surrender in title race: Guardiola
-
Korda captures weather-shortened LPGA season opener
-
Czechs rally to back president locking horns with government
-
Prominent Venezuelan activist released after over four years in jail
-
Emery riled by 'unfair' VAR call as Villa's title hopes fade
-
Guirassy double helps Dortmund move six points behind Bayern
-
Nigeria's president pays tribute to Fela Kuti after Grammys Award
-
Inter eight clear after win at Cremonese marred by fans' flare flinging
-
England underline World Cup
credentials with series win over Sri Lanka
-
Guirassy brace helps Dortmund move six behind Bayern
-
Man City held by Solanke stunner, Sesko delivers 'best feeling' for Man Utd
-
'Send Help' debuts atop N.America box office
-
Ukraine war talks delayed to Wednesday, says Zelensky
-
Iguanas fall from trees in Florida as icy weather bites southern US
-
Carrick revels in 'best feeling' after Man Utd leave it late
-
Olympic chiefs admit 'still work to do' on main ice hockey venue
-
Pope says Winter Olympics 'rekindle hope' for world peace
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
P.A.Mendoza--AT